• Je něco špatně v tomto záznamu ?

Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties

G. de Andrade Ramos, A. Souza de Oliveira, M. Bartolini, M. Naldi, I. Liparulo, C. Bergamini, E. Uliassi, L. Wu, PE. Fraser, M. Abreu, AS. Kiametis, R. Gargano, ER. Silveira, GD. Brand, L. Prchal, O. Soukup, J. Korábečný, ML. Bolognesi, LA. Soares Romeiro

. 2021 ; 12 (7) : 1154-1163. [pub] 20210505

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024647

As part of our efforts to develop sustainable drugs for Alzheimer's disease (AD), we have been focusing on the inexpensive and largely available cashew nut shell liquid (CNSL) as a starting material for the identification of new acetylcholinesterase (AChE) inhibitors. Herein, we decided to investigate whether cardanol, a phenolic CNSL component, could serve as a scaffold for improved compounds with concomitant anti-amyloid and antioxidant activities. Ten new derivatives, carrying the intact phenolic function and an aminomethyl functionality, were synthesized and first tested for their inhibitory potencies towards AChE and butyrylcholinesterase (BChE). 5 and 11 were found to inhibit human BChE at a single-digit micromolar concentration. Transmission electron microscopy revealed the potential of five derivatives to modulate Aβ aggregation, including 5 and 11. In HORAC assays, 5 and 11 performed similarly to standard antioxidant ferulic acid as hydroxyl scavenging agents. Furthermore, in in vitro studies in neuronal cell cultures, 5 and 11 were found to effectively inhibit reactive oxygen species production at a 10 μM concentration. They also showed a favorable initial ADME/Tox profile. Overall, these results suggest that CNSL is a promising raw material for the development of potential disease-modifying treatments for AD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024647
003      
CZ-PrNML
005      
20211013133832.0
007      
ta
008      
211006s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1039/d1md00046b $2 doi
035    __
$a (PubMed)34355181
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a de Andrade Ramos, Giselle $u Department of Pharmacy, Health Sciences Faculty, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil luizromeiro@unb.br
245    10
$a Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties / $c G. de Andrade Ramos, A. Souza de Oliveira, M. Bartolini, M. Naldi, I. Liparulo, C. Bergamini, E. Uliassi, L. Wu, PE. Fraser, M. Abreu, AS. Kiametis, R. Gargano, ER. Silveira, GD. Brand, L. Prchal, O. Soukup, J. Korábečný, ML. Bolognesi, LA. Soares Romeiro
520    9_
$a As part of our efforts to develop sustainable drugs for Alzheimer's disease (AD), we have been focusing on the inexpensive and largely available cashew nut shell liquid (CNSL) as a starting material for the identification of new acetylcholinesterase (AChE) inhibitors. Herein, we decided to investigate whether cardanol, a phenolic CNSL component, could serve as a scaffold for improved compounds with concomitant anti-amyloid and antioxidant activities. Ten new derivatives, carrying the intact phenolic function and an aminomethyl functionality, were synthesized and first tested for their inhibitory potencies towards AChE and butyrylcholinesterase (BChE). 5 and 11 were found to inhibit human BChE at a single-digit micromolar concentration. Transmission electron microscopy revealed the potential of five derivatives to modulate Aβ aggregation, including 5 and 11. In HORAC assays, 5 and 11 performed similarly to standard antioxidant ferulic acid as hydroxyl scavenging agents. Furthermore, in in vitro studies in neuronal cell cultures, 5 and 11 were found to effectively inhibit reactive oxygen species production at a 10 μM concentration. They also showed a favorable initial ADME/Tox profile. Overall, these results suggest that CNSL is a promising raw material for the development of potential disease-modifying treatments for AD.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Souza de Oliveira, Andressa $u Department of Pharmacy, Health Sciences Faculty, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil luizromeiro@unb.br
700    1_
$a Bartolini, Manuela $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Naldi, Marina $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Liparulo, Irene $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Bergamini, Christian $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Uliassi, Elisa $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Wu, Ling $u Tanz Centre for Research in Neurodegenerative Diseases and Dept. of Medical Biophysics, University of Toronto Krembil Discovery Tower, 60 Leonard Avenue, 6KD-402 M5T 2S8 Toronto ON Canada
700    1_
$a Fraser, Paul E $u Tanz Centre for Research in Neurodegenerative Diseases and Dept. of Medical Biophysics, University of Toronto Krembil Discovery Tower, 60 Leonard Avenue, 6KD-402 M5T 2S8 Toronto ON Canada
700    1_
$a Abreu, Monica $u Physics Institute, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil
700    1_
$a Kiametis, Alessandra Sofia $u Physics Institute, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil
700    1_
$a Gargano, Ricardo $u Physics Institute, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil
700    1_
$a Silveira, Edilberto Rocha $u CENAUREMN, Department of Organic and Inorganic Chemistry, Federal University of Ceará 60021-970 Fortaleza CE Brazil
700    1_
$a Brand, Guilherme D $u Chemistry Institute, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil
700    1_
$a Prchal, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove Sokolska 581, 500 05 Hradec Kralove Czech Republic
700    1_
$a Soukup, Ondřej $u Biomedical Research Centre, University Hospital Hradec Kralove Sokolska 581, 500 05 Hradec Kralove Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence Trebesska 1575, 500 01 Hradec Kralove Czech Republic
700    1_
$a Korábečný, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove Sokolska 581, 500 05 Hradec Kralove Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence Trebesska 1575, 500 01 Hradec Kralove Czech Republic
700    1_
$a Bolognesi, Maria Laura $u Department of Pharmacy and Biotechnology, University of Bologna Via Belmeloro 6 40126 Bologna Italy marialaura.bolognesi@unibo.it
700    1_
$a Soares Romeiro, Luiz Antonio $u Department of Pharmacy, Health Sciences Faculty, University of Brasília, Campus Universitário Darcy Ribeiro 70910-900 Brasília DF Brazil luizromeiro@unb.br
773    0_
$w MED00208004 $t RSC medicinal chemistry $x 2632-8682 $g Roč. 12, č. 7 (2021), s. 1154-1163
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34355181 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013133829 $b ABA008
999    __
$a ind $b bmc $g 1708408 $s 1145144
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c 7 $d 1154-1163 $e 20210505 $i 2632-8682 $m RSC medicinal chemistry $n RSC med. chem. $x MED00208004
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace